Noel G. McElvaney

25.4k total citations · 6 hit papers
360 papers, 17.8k citations indexed

About

Noel G. McElvaney is a scholar working on Pulmonary and Respiratory Medicine, Cancer Research and Oncology. According to data from OpenAlex, Noel G. McElvaney has authored 360 papers receiving a total of 17.8k indexed citations (citations by other indexed papers that have themselves been cited), including 182 papers in Pulmonary and Respiratory Medicine, 111 papers in Cancer Research and 63 papers in Oncology. Recurrent topics in Noel G. McElvaney's work include Cystic Fibrosis Research Advances (101 papers), Protease and Inhibitor Mechanisms (98 papers) and Neonatal Respiratory Health Research (74 papers). Noel G. McElvaney is often cited by papers focused on Cystic Fibrosis Research Advances (101 papers), Protease and Inhibitor Mechanisms (98 papers) and Neonatal Respiratory Health Research (74 papers). Noel G. McElvaney collaborates with scholars based in Ireland, United States and United Kingdom. Noel G. McElvaney's co-authors include Catherine M. Greene, Shane O’Neill, Clifford C. Taggart, Ronald G. Crystal, Emer P. Reeves, Sanjay H. Chotirmall, Tomás P. Carroll, P. Birrer, Oliver J. McElvaney and Hidenori Nakamura and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Nucleic Acids Research.

In The Last Decade

Noel G. McElvaney

335 papers receiving 17.4k citations

Hit Papers

A CFTR Potentiator in Pat... 1992 2026 2003 2014 2011 1994 1992 2015 2020 500 1000 1.5k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
    2011 1.5k citations Noel G. McElvaney et al. profile →
  2. Administration of an adenovirus containing the human CFTR cDNA to the respiratory tract of individuals with cystic fibrosis
    1994 654 citations Noel G. McElvaney et al. profile →
  3. Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line.
    1992 411 citations Noel G. McElvaney et al. profile →
  4. Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial
    2015 325 citations Noel G. McElvaney et al. profile →
  5. Alpha 1 -Antitrypsin Deficiency
    2020 265 citations Noel G. McElvaney et al. profile →
  6. Interleukin-6: obstacles to targeting a complex cytokine in critical illness
    2021 155 citations Oliver J. McElvaney, Gerard F. Curley et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Noel G. McElvaney Ireland 74 8.7k 4.6k 3.6k 2.7k 2.3k 360 17.8k
Robert Homer United States 72 7.9k 0.9× 5.6k 1.2× 1.9k 0.5× 7.0k 2.7× 2.5k 1.1× 203 21.2k
Masahiro Asaka Japan 63 5.6k 0.6× 3.3k 0.7× 1.2k 0.3× 3.4k 1.3× 2.8k 1.2× 507 18.0k
Cory M. Hogaboam United States 78 6.7k 0.8× 3.9k 0.8× 926 0.3× 6.9k 2.6× 2.3k 1.0× 322 18.9k
Theodore J. Standiford United States 79 4.0k 0.5× 4.5k 1.0× 1.2k 0.3× 7.2k 2.7× 1.9k 0.8× 237 17.3k
Emad El‐Omar United Kingdom 66 6.0k 0.7× 5.5k 1.2× 1.3k 0.4× 4.8k 1.8× 2.5k 1.1× 228 24.7k
Hans Gelderblom Netherlands 76 9.6k 1.1× 5.8k 1.2× 2.3k 0.7× 1.9k 0.7× 9.6k 4.2× 743 25.3k
Roland M. Schmid Germany 77 2.7k 0.3× 7.4k 1.6× 3.7k 1.0× 5.0k 1.9× 6.3k 2.7× 480 20.8k
Georges E. Grau Australia 83 2.5k 0.3× 6.4k 1.4× 2.1k 0.6× 9.5k 3.6× 2.2k 0.9× 364 26.1k
Tsutomu Chiba Japan 78 2.8k 0.3× 8.0k 1.7× 1.9k 0.5× 4.2k 1.6× 4.5k 2.0× 603 24.2k
Johannes Roth Germany 86 2.9k 0.3× 12.9k 2.8× 2.3k 0.7× 11.4k 4.3× 1.8k 0.8× 311 24.0k

Countries citing papers authored by Noel G. McElvaney

Since Specialization
Citations

This map shows the geographic impact of Noel G. McElvaney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Noel G. McElvaney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Noel G. McElvaney more than expected).

Fields of papers citing papers by Noel G. McElvaney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Noel G. McElvaney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Noel G. McElvaney. The network helps show where Noel G. McElvaney may publish in the future.

Co-authorship network of co-authors of Noel G. McElvaney

This figure shows the co-authorship network connecting the top 25 collaborators of Noel G. McElvaney. A scholar is included among the top collaborators of Noel G. McElvaney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Noel G. McElvaney. Noel G. McElvaney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Turner, Alice, Joachim H. Ficker, Andrea Vianello, et al.. (2025). Advancing the understanding and treatment of lung pathologies associated with alpha 1 antitrypsin deficiency. Therapeutic Advances in Respiratory Disease. 19. 2703898169–2703898169. 2 indexed citations
2.
3.
Carroll, Tomás P., et al.. (2023). CPC01 A puzzling panniculitis. British Journal of Dermatology. 188(Supplement_4).
4.
McElvaney, Oliver J., Brian Cleary, Oisín F. McElvaney, et al.. (2023). Safety and Reactogenicity of COVID-19 Vaccination in Severe Alpha-1 Antitrypsin Deficiency. Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation. 11(1). 3–12. 3 indexed citations
5.
McElvaney, Oliver J., Eoin O’Connor, Natalie McEvoy, et al.. (2020). Alpha-1 antitrypsin for cystic fibrosis complicated by severe cytokinemic COVID-19. Journal of Cystic Fibrosis. 20(1). 31–35. 13 indexed citations
6.
O’Brien, Helen, E O’Brien, Ross Morgan, et al.. (2020). An integrated multidisciplinary model of COVID-19 recovery care. Irish Journal of Medical Science (1971 -). 190(2). 461–468. 47 indexed citations
7.
McElvaney, Oisín F., Mark P. Murphy, Emer P. Reeves, & Noel G. McElvaney. (2020). Anti-cytokines as a Strategy in Alpha-1 Antitrypsin Deficiency. Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation. 7(3). 203–213. 14 indexed citations
8.
Mueller, Christian, Gwladys Gernoux, Alisha M. Gruntman, et al.. (2017). 5 Year Expression and Neutrophil Defect Repair after Gene Therapy in Alpha-1 Antitrypsin Deficiency. Molecular Therapy. 25(6). 1387–1394. 82 indexed citations
9.
Mirković, Bojana, Michelle Murray, Gillian Lavelle, et al.. (2015). The Role of Short-Chain Fatty Acids, Produced by Anaerobic Bacteria, in the Cystic Fibrosis Airway. American Journal of Respiratory and Critical Care Medicine. 192(11). 1314–1324. 99 indexed citations
10.
Oglesby, Irene, Sebastian Vencken, Raman Agrawal, et al.. (2015). miR-17 overexpression in cystic fibrosis airway epithelial cells decreases interleukin-8 production. European Respiratory Journal. 46(5). 1350–1360. 62 indexed citations
11.
Geraghty, Patrick, Edward Eden, Manju Pillai, et al.. (2014). α1-Antitrypsin Activates Protein Phosphatase 2A to Counter Lung Inflammatory Responses. American Journal of Respiratory and Critical Care Medicine. 190(11). 1229–1242. 41 indexed citations
12.
Molloy, Kevin, Craig P. Hersh, Valerie B. Morris, et al.. (2014). Clarification of the Risk of Chronic Obstructive Pulmonary Disease in α1-Antitrypsin Deficiency PiMZ Heterozygotes. American Journal of Respiratory and Critical Care Medicine. 189(4). 419–427. 118 indexed citations
13.
Weldon, Sinéad, Paul McNally, Daniel F. McAuley, et al.. (2014). miR-31 Dysregulation in Cystic Fibrosis Airways Contributes to Increased Pulmonary Cathepsin S Production. American Journal of Respiratory and Critical Care Medicine. 190(2). 165–174. 69 indexed citations
14.
Hassan, Tidi, Tomás P. Carroll, Patrick G. Buckley, et al.. (2013). miR-199a-5p Silencing Regulates the Unfolded Protein Response in Chronic Obstructive Pulmonary Disease and α1-Antitrypsin Deficiency. American Journal of Respiratory and Critical Care Medicine. 189(3). 263–273. 64 indexed citations
15.
Chotirmall, Sanjay H., J. A. A. Renwick, Tidi Hassan, et al.. (2012). The Effect of Aspergillus fumigatus Infection on Vitamin D Receptor Expression in Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 186(10). 999–1007. 83 indexed citations
16.
Reeves, Emer P., Michael Williamson, Shane O’Neill, Peter Greally, & Noel G. McElvaney. (2011). Nebulized Hypertonic Saline Decreases IL-8 in Sputum of Patients with Cystic Fibrosis. American Journal of Respiratory and Critical Care Medicine. 183(11). 1517–1523. 70 indexed citations
17.
Chotirmall, Sanjay H., Catherine M. Greene, Irene Oglesby, et al.. (2010). 17β-Estradiol Inhibits IL-8 in Cystic Fibrosis by Up-Regulating Secretory Leucoprotease Inhibitor. American Journal of Respiratory and Critical Care Medicine. 182(1). 62–72. 74 indexed citations
18.
Greene, Catherine M., Teck Boon Low, Shane O’Neill, & Noel G. McElvaney. (2009). Anti–Proline-Glycine-Proline or Antielastin Autoantibodies Are Not Evident in Chronic Inflammatory Lung Disease. American Journal of Respiratory and Critical Care Medicine. 181(1). 31–35. 57 indexed citations
19.
McElvaney, Noel G.. (2003). Alpha-1 Antitrypsin Therapy in Cystic Fibrosis and the Lung Disease Associated with Alpha-1 Antitrypsin Deficiency.. PubMed. 13 Suppl 2(5). 15–16. 29 indexed citations
20.
Devaney, James, Catherine M. Greene, Clifford C. Taggart, et al.. (2003). Neutrophil elastase up‐regulates interleukin‐8 via toll‐like receptor 4. FEBS Letters. 544(1-3). 129–132. 192 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Robert Homer Breakdown of academic impact, for papers by Masahiro Asaka Breakdown of academic impact, for papers by Cory M. Hogaboam Breakdown of academic impact, for papers by Theodore J. Standiford Breakdown of academic impact, for papers by Emad El‐Omar Breakdown of academic impact, for papers by Hans Gelderblom Breakdown of academic impact, for papers by Roland M. Schmid Breakdown of academic impact, for papers by Georges E. Grau Breakdown of academic impact, for papers by Tsutomu Chiba Breakdown of academic impact, for papers by Johannes Roth
Rankless by CCL
2026